Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8998400 | Neuropharmacology | 2005 | 10 Pages |
Abstract
This study examines the effect of long-term elevation of brain monoamine levels on receptor/G-protein coupling by chronic administration of a highly potent tropane analog, WF-23 (2β-propanoyl-3β-(2-naphthyl) tropane). WF-23 blocks dopamine, serotonin and norepinephrine transporters with high affinity in vitro, and blocks transporters for at least two days following a single in vivo administration. Rats were chronically treated for 15 days with 1 mg/kg WF-23, injected i.p. every two days. Receptor activation of G-proteins was determined by [35S]GTPγS autoradiography in brain sections for D2, 5-HT1A and α2-adrenergic receptors, as well as mu opioid receptors as a non-monoamine receptor control. Chronic treatment with WF-23 produced significant reductions in D2, 5-HT1A, and α2-adrenergic receptor-stimulated [35S]GTPγS binding in caudate/putamen, hippocampus and amygdala, respectively. There were no effects of WF-23 treatment on mu opioid-stimulated [35S]GTPγS binding. Additionally, there was no effect of WF-23 treatment on D2 receptor binding, as determined by [3H]spiperone autoradiography. These data show that chronic blockade of monoamine transporters produces specific uncoupling of receptors and G-proteins in specific brain regions in the absence of receptor downregulation.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Kerry Ann O'Connor, Timothy C. Gregg, Huw M.L. Davies, Steven R. Childers,